The Evaluation of Antibiotic Consumption at the Inpatient Level in Kazakhstan from 2011 to 2018
Open Access
- 2 February 2020
- journal article
- research article
- Published by MDPI AG in Antibiotics
- Vol. 9 (2) , 57
Abstract
Antimicrobial agents have a rather special position due to their importance as essential medicines for the treatment of infectious diseases. Evidence-based prescriptions are needed to optimize the use of antimicrobials in humans, as well as to decrease antimicrobial resistance. The aim of this study was to assess the inpatient consumption of antimicrobial drugs for systemic use in the period 2011–2018 in Kazakhstan. This article presents the results of an evaluation of the inpatient use of antibacterial drugs for systemic use (group J01) for the period 2011–2018 using the anatomical therapeutic chemical (ATC) classification)/defined daily dose (DDD) methodology recommended by the World Health Organization. Inpatient antimicrobial utilization is expressed as DDDs/1000 inhabitants/day (DID). The results of the assessment for inpatient antibiotic use (over an eight-year period) showed a decrease in the total consumption of antibiotics for systemic action in Kazakhstan (2011: 12.72 DID; 2018: 2.74 DID). Among oral formulations, levofloxacin was consumed the most, and cefazolin was consumed the most among the parenteral formulations of antimicrobials. The three drugs consumed the most included cefazolin (first-generation cephalosporin), ceftriaxone (third-generation cephalosporin), and cefuroxime (second-generation cephalosporin). The total consumption of antibacterials for systemic action in Kazakhstan decreased during the analyzed period, but there was an irrational use of certain groups of drugs.Keywords
This publication has 10 references indexed in Scilit:
- Antibiotic drug-resistance as a complex system driven by socio-economic growth and antibiotic misuseScientific Reports, 2019
- Antimicrobial Medicines Consumption in Eastern Europeand Central Asia – An Updated Cross-National Study and Assessment of QuantitativeMetrics for Policy ActionFrontiers in Pharmacology, 2019
- Occurrence of the potent mutagens 2- nitrobenzanthrone and 3-nitrobenzanthrone in fine airborne particlesScientific Reports, 2019
- Antibiotic Resistance in Syria: A Local Problem Turns Into a Global ThreatFrontiers in Public Health, 2018
- Recent Initiatives in the Republic of Srpska to Enhance Appropriate Use of Antibiotics in Ambulatory Care; Their Influence and ImplicationsFrontiers in Pharmacology, 2018
- Economic burden of antibiotic resistance: how much do we really know?Clinical Microbiology and Infection, 2014
- The Antimicrobial Resistance Crisis: Causes, Consequences, and ManagementFrontiers in Public Health, 2014
- Antibiotic use in eastern Europe: a cross-national database study in coordination with the WHO Regional Office for EuropeThe Lancet Infectious Diseases, 2014
- Feasibility and impact of an intensified antibiotic stewardship programme targeting cephalosporin and fluoroquinolone use in a tertiary care university medical centerBMC Infectious Diseases, 2014
- 25 years of the WHO essential medicines lists: progress and challengesThe Lancet, 2003